Background: Cardiac risk-adjustment indices for acute coronary syndromes have important clinical and research applications, especially if proven to be valid and robust across heterogeneous socioeconomically diverse populations. The objective of this study was to validate the Global Registry of Acute Coronary Events (GRACE) risk-adjustment index for 6-month all-cause mortality across socioeconomic strata.
Methods: The study cohort consisted of patients who were enrolled in the SESAMI study and discharged alive from the hospital between December 1, 1999, and February 28, 2003. Socioeconomic information was obtained through self-report. Hospital chart abstraction was used to ascertain clinical detail required for the derivation of the GRACE risk index. Six-month mortality rates were obtained through data linkage using encrypted health card numbers. The accuracy (c-statistic) and calibration (Hosmer-Lemeshow) characteristics of the GRACE risk index were generated using logistic regression across income and education strata.
Results: Predicted and observed mortality rates were significantly higher among patients of lower incomes and education (ie, observed 6-month mortality: 5.1% vs 1.8% among low income vs high income patients, respectively, P < .0001; 4.6% vs 2.9% among low-educated vs highly educated patients, respectively, P = .02). The predicted 6-month mortality as derived using GRACE closely mirrored observed mortality rates with strong accuracy and precision (c-statistic = 0.80 for the overall cohort and within each income and education strata; Hosmer-Lemeshow goodness-of-fit test was not significant within each income and education strata).
Conclusion: The GRACE risk score for 6-month all-cause mortality is an accurate, well-calibrated, and robust predictor across socioeconomic strata and can be used as a valid risk-adjustment index when examining socioeconomic-mortality differences after acute MI.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ahj.2005.07.013 | DOI Listing |
BMC Cardiovasc Disord
January 2025
Graduate School of Public Health, St Luke's International University, Tokyo, Japan.
Background: Recent studies revealed an association between small kidney volume and progression of kidney dysfunction in particular settings such as kidney transplantation and transcatheter aortic valve implantation. We hypothesized that kidney volume was associated with the incidence of kidney-related adverse outcomes such as worsening renal function (WRF) in patients with acute heart failure (AHF).
Methods: This study was a single-center retrospective cohort study.
Mol Diagn Ther
January 2025
Department of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, 4288A-1151 Richmond Street North, London, ON, N6A 5B7, Canada.
Clinical endpoints caused by hyperlipoproteinemia include atherosclerotic cardiovascular disease and acute pancreatitis. Emerging lipid-lowering therapies targeting proprotein convertase subtilisin/kexin 9 (PCSK9), lipoprotein(a), apolipoprotein C-III, and angiopoietin-like protein 3 represent promising advances in the management of patients with hyperlipoproteinemia. These therapies offer novel approaches for lowering pathogenic lipid and lipoprotein species, particularly in patients with serious perturbations who are not adequately controlled with conventional treatments or who are unable to tolerate them.
View Article and Find Full Text PDFNat Commun
January 2025
Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Complete blood count indices and their ratios are associated with adverse clinical outcomes for many acute illnesses, but the mechanisms generating these associations are not fully understood. Recent identification of a consistent pattern of white blood cell and platelet count co-regulation during acute inflammatory recovery provides a potentially unifying explanation. Here we show that the platelet-to-white-cell ratio, which was selected based on this conserved recovery pattern, is more strongly associated with mortality than other blood count markers and ratios in four important illnesses involving acute inflammation: COVID-19, acute heart failure, myocardial infarction, and stroke.
View Article and Find Full Text PDFRes Social Adm Pharm
January 2025
Laboratory of Teaching and Research in Social Pharmacy (LEPFS), Department of Pharmacy, Federal University of Sergipe, Cidade Universitária "Prof. José Aloísio Campos", Jardim Rosa Elze, São Cristóvão, SE, CEP: 49100-000, Brazil. Electronic address:
Background: The identification and reduction of drug-related problems (DRPs) through DRP-oriented medical records during the hospitalization of critically impatients can optimize health indicators, such as length of hospital stay.
Objective: To determine the effect of medical records focused on drug-related problems on the duration of stay for patients in intensive care units.
Method: A randomized controlled clinical trial was conducted with patients assigned to intervention or the usual care groups involving clinical pharmacists.
Open Heart
January 2025
Cardiology, Radboudumc, Nijmegen, The Netherlands
Background And Aims: Due to the multitude of risk factors outlined in the guidelines, personalised dual antiplatelet therapy (DAPT) guidance after percutaneous coronary intervention (PCI) is complex. A simplified method was created to facilitate the use of risk stratification. We aimed to compare the predictive and prognostic value of the 'Zuidoost Nederland Hart Registratie' (ZON-HR) classification for bleeding risk with the PREdicting bleeding Complications In patients undergoing Stent implantation and subsEquent DAPT (PRECISE-DAPT) score and to determine the effect of ticagrelor monotherapy versus DAPT in patients with or without high bleeding risk (HBR).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!